As a potential surrogate of the more laborious IF examination, the immunohistochemical evaluation of γ-H2AX and 53BP1 is applicable to GIST samples in which higher risk levels, amongst other adverse factors, are robustly associated with increased expressions of both markers. Here, TP53BP1 is linked to gastrointestinal stromal tumor.